CD38 and CD47 Targeted Alpha Therapy (TAT): Potent Alternatives to CD33 in AML

Read full text Summarise with VIRAT
Authors: Mylène Sorin, Sébastien Gouard, Séverine Marionneau‐Lambot, Clémence Maingueneau, Alfred Morgenstern, Frank Bruchertseifer, Michel Chérel, Férid Haddad, Mathilde Allard, Joëlle Gaschet
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Radiopharmaceutical Chemistry and Applications Acute Myeloid Leukemia Research Protein Degradation and Inhibitors

Publication details

Journal / source
Journal of medical imaging and radiation sciences
Volume
57
Issue
2
Pages
102233–102233
Publication date
1 March 2026
Language
EN